As reprinted in the Digital Journal http://www.digitaljournal.com/pr/1470065, the results of the Kalorama Information DNA Sequencer Survey is in. The MiSeq leads all other sequencers for number of sequencers owned by labs surveyed, at nearly 15%, compared to 13.8% for ABI/Life's first generation capillary sequencer.
“Illumina has momentum, the most popular model and clearly leads next
gen,” said Justin Saeks, the report’s author. “HiSeq sequencers of all
models are collectively even more common than the MiSeq, which further
illustrates Illumina’s market position.”